author-photo

Gregory James Crane

University of Kansas

6

Papers

26

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Romidepsin (HDACi) plus cisplatin and nivolumab triplet combination in patients with metastatic triple negative breast cancer (mTNBC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP).

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast cancer (NCT02413320).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)